Clinical Trial

Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated July 9, 2024 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study is an open-label, single-arm Phase II clinical study to evaluate the efficacy and safety of ivonescimab(AK112/SMT112) in combination with stereotactic body radiation therapy and chemotherapy in patients with pancreatic cancer
Trial Details
NCT Number NCT06491472
Lead Sponsor Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators: Akesobio
Conditions Pancreatic Cancer
Enrollment 36 participants
Start Date 2024-07-15
Primary Completion 2026-07-15 (estimated)
Study Completion 2027-07-15 (estimated)
Updated on ClinicalTrials.gov 2024-07-09